Report: Pfizer would pay $75M in Trovan case

Pfizer has agreed to pay $75 million to settle the long-running Nigerian case over a meningitis drug trial, African news sources report. The trial participants and families who sued will share the settlement with the Kano State Government in Nigeria. It's unclear at press time, however, whether all sides have approved the settlement deal. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.